Skip to content

Study · Not a test of the peptide alone · 1991

2 results

[New approaches to the treatment of mycobacterioses of the lungs].

Aleksandrova AE, Vasil'ev AV, Lozovskaia ME

Problemy tuberkuleza1 Jan 1991

PMID1852731 (opens in a new tab)PepBankPUB-01852731
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with fibro-cavernous pulmonary mycobacteriosis, the multidrug regimen containing thymalin increased bacillary excretion cessation from 30 to 82.6%.

    In plain wordsIn patients with pulmonary mycobacteriosis, the multidrug regimen containing thymalin increased bacillary excretion cessation compared with control treatment.

    Peptide
    Thymalin
    Outcome
    IncreaseBacillary excretion cessation
    Study

    n = 43

    Comparator
    Control treatment
    Outcome group
    Infection and antimicrobial activity · Infection

    Measurements

    Bacillary excretion cessation
    82.6%
    New regimen
    Bacillary excretion cessation
    30%
    Control

    Source sentences

    Summary
    Employment of the new treatment regimen significantly enhanced its efficiency--the incidence of bacillary excretion cessation increased from 30 to 82.6%.
    2 context sentences
    Summary · context
    The clinical course and results of treatment of 43 patients (23 of the main and 20 of the control group) with fibro-cavernous pulmonary mycobacteriosis were studied.
    Summary · context
    which comprised a combination of kanamycin-ethambutol-thionamide coupled with sulfadimethoxine and thymalin courses.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02AnimalNot a test of Thymalin aloneAnimal study (in vivo)Efficacy outcome

    In mice with M. avium mycobacteriosis, the regimen containing kanamycin, ethambutol, thionamide, sulfadimethoxine and thymalin was selected as most efficient.

    In plain wordsIn mice with mycobacteriosis, the multidrug regimen containing thymalin was selected as the most efficient tested regimen.

    Peptide
    Thymalin
    Outcome
    Direction not reportedTreatment regimen efficiency
    Study

    White micen: not reported in source

    M. avium mycobacteriosis
    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    In the preliminary experiments with the use of an experimental model, 32 regimens of M. avium mycobacteriosis treatment were tested on 872 white mice and the most efficient one was chosen,
    1 context sentence
    Summary · context
    which comprised a combination of kanamycin-ethambutol-thionamide coupled with sulfadimethoxine and thymalin courses.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.